Comparative Study of Post-Varicocelectomy Myo-inositol vs. Antioxidants vs. Surgery Alone in Infertile Men
Key facts
- Who runs it
- Fayoum University Hospital
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 3
- People taking part
- 150 people, planned
- Started
- 26 Oct 2026
- Expected to end
- 1 Jul 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Experimental Arm Intervention: Myo-inositol
- Conventional Antioxidants
- Group C (Control)
- Record updated
- 4 November 2026
Who can take part
- Age
- 18 years to 50 years
- Sex
- Men only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Adult male patients; Clinically palpable Grade II or Grade III varicocele undergoing varicocelectomy; Presence of primary or secondary infertility; Impaired semen analysis parameters; Reduced testicular volume
Who cannot take part
- History of previous varicocelectomy operations
- Systemic vascular or medical diseases affecting arterial flow (e.g., diabetes mellitus, hypertension, liver disease, hypercholesterolemia)
- Active genital tract infections
- Pediatric (infants) or elderly populations
- Sub-clinical varicocele
- Hormonal abnormalities or autism
- -
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this open-label, 3-arm randomized controlled trial is to compare the clinical efficacy and safety of adding oral myo-inositol versus conventional oral antioxidants (vitamin C, L-carnitine, and zinc) versus surgery alone following microscopic subinguinal varicocelectomy in infertile adult males with clinical varicocele.
The 3 groups in the trial
- Group A: Myo-inositolTreatment being tested
Surgical Intervention: Microscopic subinguinal varicocelectomy. Drug/Supplement: Oral Myo-inositol 2g tablets, twice daily for 3 to 6 months post-surgery.
Treatment: Experimental Arm Intervention: Myo-inositol
- Group B: Conventional AntioxidantsExisting treatment, for comparison
Surgical Intervention: Microscopic subinguinal varicocelectomy. Drug/Supplement: Oral Vitamin C (500mg daily) + L-Carnitine (1000mg twice daily) + Zinc (10mg twice daily) for 3 to 6 months post-surgery.
Treatment: Conventional Antioxidants
- Group C: Varicocelectomy AlonePlacebo, for comparison
Microscopic subinguinal varicocelectomy alone with no adjuvant medical therapy post-surgery.
Treatment: Group C (Control)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparative Study Between Myo-inositol Add on Post Varicocelectomy Versus Add on Conventional Antioxidants or Varicocelectomy Alone in Infertile Patients
- Criteria questions
- Built from NCT07915388, who can take part
- Record updated
- 4 November 2026